IL33 and colorectal carcinoma: In this concept, it was stated that the IL-33 mediates its functions via a heterodimeric receptor complex and a broad range of actions affecting VEGF, angiogenesis, and metastasis, in other words, they contribute to different pathways and interaction [20,21]. Studies carried out in the past decade concluded that IL-33 either promotes or inhibits CRC in different settings.